ClinConnect ClinConnect Logo
Search / Trial NCT06873880

Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients

Launched by UNIVERSITY OF TARTU · Mar 10, 2025

Trial Information

Current as of April 29, 2025

Recruiting

Keywords

Dialysis Bioelectrical Impedance Nutrition Body Composition Renal Impairment

ClinConnect Summary

This clinical trial is studying how two different methods—Bioelectrical Impedance Analysis (BIA) and estimated Glomerular Filtration Rate (eGFR)—can work together to better assess the health and nutritional status of patients who are on hemodialysis due to chronic kidney disease. Many patients undergoing dialysis face issues like malnutrition and muscle loss, but current methods to evaluate their health are often not very effective. By combining these two measurements, the researchers hope to create a more accurate and easy way to monitor patients' nutrition and overall health, which could lead to better treatment options and improved health outcomes.

To participate in this study, you must have chronic kidney disease and have been on hemodialysis for at least six months. Unfortunately, if you are pregnant, breastfeeding, have certain other serious health conditions, have a pacemaker, or have had recent surgery, you won't be eligible to join. If you qualify, you can expect to have non-invasive tests that will help researchers learn more about your body composition and kidney function. This could potentially lead to better management of your health while on dialysis. The trial is currently recruiting participants of all genders, aged between 65 and 74.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Chronic kidney disease Hemodialysis for at least 6 months
  • Exclusion Criteria:
  • Pregnancy Lactation Major second pathology Pacemaker Recent surgery

About University Of Tartu

The University of Tartu, located in Estonia, is a prestigious research institution recognized for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, the university leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the broader medical community. With a focus on ethical practices, collaboration, and scientific excellence, the University of Tartu is dedicated to fostering groundbreaking studies that address critical health challenges and enhance the understanding of complex medical conditions.

Locations

Tartu, Tartumaa, Estonia

Patients applied

0 patients applied

Trial Officials

Alastair Forbes, MD

Study Director

University of Tartu

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported